These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25495978)

  • 1. Enhancing antibiotic activity to combat resistant Gram-negative bacteria: what's next?
    Bolla JM; Brunel JM
    Future Med Chem; 2014; 6(17):1849-51. PubMed ID: 25495978
    [No Abstract]   [Full Text] [Related]  

  • 2. Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline?
    Koulenti D; Song A; Ellingboe A; Abdul-Aziz MH; Harris P; Gavey E; Lipman J
    Int J Antimicrob Agents; 2019 Mar; 53(3):211-224. PubMed ID: 30394301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistant gram-negative infections.
    Fraimow H; Nahra R
    Crit Care Clin; 2013 Oct; 29(4):895-921. PubMed ID: 24094384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous colistimethate for multidrug-resistant Gram-negative bacteria.
    Zavascki AP; Li J
    Lancet Infect Dis; 2008 Jul; 8(7):403-5. PubMed ID: 18582831
    [No Abstract]   [Full Text] [Related]  

  • 5. New Insights into Infections due to Multidrug Resistant Gram Negative Bacteria: The Interplay between Lab and Clinic.
    Oliva A; Giacobbe DR; Di Luca M; Miller NS
    Biomed Res Int; 2018; 2018():8905874. PubMed ID: 30671476
    [No Abstract]   [Full Text] [Related]  

  • 6. What's new in the treatment of multidrug-resistant gram-negative infections?
    Mo Y; Lorenzo M; Farghaly S; Kaur K; Housman ST
    Diagn Microbiol Infect Dis; 2019 Feb; 93(2):171-181. PubMed ID: 30224228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial AApeptides.
    Sang P; Shi Y; Teng P; Cao A; Xu H; Li Q; Cai J
    Curr Top Med Chem; 2017; 17(11):1266-1279. PubMed ID: 27758686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monotherapy vs. combined therapy in the treatment of multi-drug resistance gramnegative bacteria].
    Martínez-Sagasti F; González-Gallego MA; Moneo-González A
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():43-6. PubMed ID: 27608313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug-Resistant Gram-Negative Organisms (MDRGNO) Information for patients, relatives and visitors.
    J Hosp Infect; 2016 Jan; 92(1):88-91. PubMed ID: 27158704
    [No Abstract]   [Full Text] [Related]  

  • 11. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiological findings from the Haiti disaster.
    Marra AR; Valle Martino MD; Ribas MR; Rodriguez-Taveras C; Pavao Dos Santos OF
    Travel Med Infect Dis; 2012 May; 10(3):157-61. PubMed ID: 22521601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of 'old antibiotics' against highly resistant Gram-negative bacteria.
    Dubourg G; Okdah L; Le Page S; Rolain JM; Raoult D
    Int J Antimicrob Agents; 2015 Dec; 46(6):718-20. PubMed ID: 26589488
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
    Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
    Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
    [No Abstract]   [Full Text] [Related]  

  • 16. Squalamine, an original chemosensitizer to combat antibiotic-resistant gram-negative bacteria.
    Lavigne JP; Brunel JM; Chevalier J; Pagès JM
    J Antimicrob Chemother; 2010 Apr; 65(4):799-801. PubMed ID: 20147322
    [No Abstract]   [Full Text] [Related]  

  • 17. Multidrug-resistant (MDR) Gram-negative bacteria information leaflets.
    Brown C; Livermore DM; Otter JA; Warren RE; Jenks P; Enoch DA; Newsholme W; Oppenheim B; Leanord A; McNulty C; Tanner G; Bennett S; Cann M; Bostock J; Collins E; Peckitt S; Ritchie L; Fry C; Hawkey P; Wilson AP
    J Hosp Infect; 2016 Jan; 92(1):86-7. PubMed ID: 27158703
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of new polymyxin derivatives for multi-drug resistant Gram-negative infections.
    Brown P; Dawson MJ
    J Antibiot (Tokyo); 2017 Apr; 70(4):386-394. PubMed ID: 28074057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug-resistant Gram-negative bacterial infections: the emerging threat and potential novel treatment options.
    Vergidis PI; Falagas ME
    Curr Opin Investig Drugs; 2008 Feb; 9(2):176-83. PubMed ID: 18246520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study on the effects of colistin therapy in children with multidrug-resistant Gram-negative bacterial pathogens: impact of HIV status on outcome.
    Dimitriades K; Morrow BM; Jeena P
    Arch Dis Child; 2014 Mar; 99(3):262-6. PubMed ID: 24170687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.